These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 17006756

  • 1. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
    Tokunaga E, Oki E, Kimura Y, Yamanaka T, Egashira A, Nishida K, Koga T, Morita M, Kakeji Y, Maehara Y.
    Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
    [Abstract] [Full Text] [Related]

  • 2. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS, Kim SW.
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [Abstract] [Full Text] [Related]

  • 3. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.
    Kim HJ, Cui X, Hilsenbeck SG, Lee AV.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 2):1013s-1018s. PubMed ID: 16467118
    [Abstract] [Full Text] [Related]

  • 4. PTEN, more than the AKT pathway.
    Blanco-Aparicio C, Renner O, Leal JF, Carnero A.
    Carcinogenesis; 2007 Jul 01; 28(7):1379-86. PubMed ID: 17341655
    [Abstract] [Full Text] [Related]

  • 5. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer.
    Tokunaga E, Kataoka A, Kimura Y, Oki E, Mashino K, Nishida K, Koga T, Morita M, Kakeji Y, Baba H, Ohno S, Maehara Y.
    Eur J Cancer; 2006 Mar 01; 42(5):629-35. PubMed ID: 16464571
    [Abstract] [Full Text] [Related]

  • 6. High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.
    Schmitz KJ, Grabellus F, Callies R, Otterbach F, Wohlschlaeger J, Levkau B, Kimmig R, Schmid KW, Baba HA.
    Breast Cancer Res; 2005 Mar 01; 7(2):R194-203. PubMed ID: 15743500
    [Abstract] [Full Text] [Related]

  • 7. Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
    Niu G, Carter WB.
    Cancer Res; 2007 Feb 15; 67(4):1487-93. PubMed ID: 17308086
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518
    [Abstract] [Full Text] [Related]

  • 9. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 10. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S, Srivastava RK.
    Int J Oncol; 2007 Apr 27; 30(4):905-18. PubMed ID: 17332930
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
    Yamashita H, Nishio M, Kobayashi S, Ando Y, Sugiura H, Zhang Z, Hamaguchi M, Mita K, Fujii Y, Iwase H.
    Breast Cancer Res; 2005 Apr 27; 7(5):R753-64. PubMed ID: 16168121
    [Abstract] [Full Text] [Related]

  • 12. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
    Hua KT, Way TD, Lin JK.
    Mol Carcinog; 2006 Aug 27; 45(8):551-60. PubMed ID: 16637063
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG.
    Cancer Res; 2008 May 01; 68(9):3152-60. PubMed ID: 18451140
    [Abstract] [Full Text] [Related]

  • 14. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.
    Tokunaga E, Okada S, Yamashita N, Akiyoshi S, Kitao H, Morita M, Kakeji Y, Maehara Y.
    Breast Cancer; 2012 Apr 01; 19(2):161-9. PubMed ID: 21063923
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
    Aleskandarany MA, Rakha EA, Ahmed MA, Powe DG, Ellis IO, Green AR.
    Breast Cancer Res Treat; 2011 Jun 01; 127(2):407-16. PubMed ID: 20617378
    [Abstract] [Full Text] [Related]

  • 16. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein.
    Ogawa T, Nagashima Y, Wada H, Akimoto K, Chiba Y, Nagatani T, Inayama Y, Yao M, Aoki I, Ikezawa Z.
    Hum Pathol; 2005 Dec 01; 36(12):1273-80. PubMed ID: 16311120
    [Abstract] [Full Text] [Related]

  • 17. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
    Chang CJ, Chiu JH, Tseng LM, Chang CH, Chien TM, Wu CW, Lui WY.
    Eur J Clin Invest; 2006 Aug 01; 36(8):588-96. PubMed ID: 16893382
    [Abstract] [Full Text] [Related]

  • 18. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J.
    Oncogene; 2007 Aug 02; 26(35):5046-59. PubMed ID: 17310986
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.
    Razis E, Bobos M, Kotoula V, Eleftheraki AG, Kalofonos HP, Pavlakis K, Papakostas P, Aravantinos G, Rigakos G, Efstratiou I, Petraki K, Bafaloukos D, Kostopoulos I, Pectasides D, Kalogeras KT, Skarlos D, Fountzilas G.
    Breast Cancer Res Treat; 2011 Jul 02; 128(2):447-56. PubMed ID: 21594665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.